✦ LIBER ✦

Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: subgroup analyses of the CONFIRM study

✍ Scribed by Hutchinson, Michael; Fox, Robert J.; Miller, David H.; Phillips, J. Theodore; Kita, Mariko; Havrdova, Eva; OâGorman, John; Zhang, Ray; Novas, Mark; Viglietta, Vissia; Dawson, Katherine T.

Book ID: 120427202
Publisher: Springer
Year: 2013
Tongue: English
Weight: 398 KB
Volume: 260
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-013-6968-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical efficacy of BG-12 (dimethyl fum

Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: subgroup analyses of the DEFINE study

✍ Bar-Or, Amit; Gold, Ralf; Kappos, Ludwig; Arnold, Douglas L.; Giovannoni, Gavin; 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 351 KB

Effects of BG-12 (dimethyl fumarate) on

Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study

✍ Kita, M.; Fox, R. J.; Phillips, J. T.; Hutchinson, M.; Havrdova, E.; Sarda, S. P 📂 Article 📅 2013 🏛 SAGE Publications 🌐 English ⚖ 580 KB

Gastrointestinal tolerability events in

Gastrointestinal tolerability events in relapsing–/INS;remitting multiple sclerosis patients treated with BG-12 (dimethyl fumarate): Integrated analysis of DEFINE and CONFIRM

✍ Havrdova, E.; Phillips, J.T.; Selmaj, K.; Gold, R.; Fox, R.J.; Giovannoni, G.; P 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Clinical and neuroradiological effect of

Clinical and neuroradiological effect of BG-12 (dimethyl fumarate) in subgroups of patients with relapsing–remitting multiple sclerosis (RRMS): An integrated analysis of the phase 3 define and confirm studies

✍ Bar-Or, A; Fox, RJ; Gold, R; Miller, DH; Arnold, DL; O'Gorman, J; Yang, M; Sheik 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

The Cost Effectiveness of BG-12 (Dimethy

The Cost Effectiveness of BG-12 (Dimethyl Fumarate) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada

✍ Su, W.; Walker, A.; Sarda, S.; Kansal, A.R.; Vicente, C.; Deniz, B. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Effect of BG-12 on contrast-enhanced les

Effect of BG-12 on contrast-enhanced lesions in patients with relapsing- remitting multiple sclerosis: subgroup analyses from the phase 2b study

✍ Kappos, L.; Gold, R.; Miller, D. H.; MacManus, D. G.; Havrdova, E.; Limmroth, V. 📂 Article 📅 2011 🏛 SAGE Publications 🌐 English ⚖ 494 KB